Keyphrases
Intensive Care Unit
100%
Severe Sepsis
100%
Multicenter Randomized Trial
100%
Lactams
100%
Intermittent Infusion
100%
Confidence Interval
66%
Antibiotics
66%
β-lactam Antibiotics
66%
Clinical Cure
66%
Bacteremia
66%
Continuous Infusion
66%
Organ Failure
66%
Failure-free
66%
Hazard Ratio
33%
Odds Ratio
33%
Improved Outcomes
33%
Randomized Controlled Trial
33%
Critically Ill Patients
33%
Health Assessment
33%
Chronic Conditions
33%
Acute Physiology
33%
Antibiotic Administration
33%
Treatment Course
33%
Intensive Care Unit Discharge
33%
Piperacillin-tazobactam
33%
Meropenem
33%
Day 14
33%
Intermittent Dosing
33%
Antibacterial Activity
33%
Ticarcillin-clavulanate
33%
Pharmacology, Toxicology and Pharmaceutical Science
Sepsis
100%
Lactam
100%
Beta Lactam Antibiotic
66%
Bloodstream Infection
66%
Randomized Controlled Trial
33%
Piperacillin Plus Tazobactam
33%
Meropenem
33%
Clavulanic Acid
33%
Antibacterial Activity
33%
Ticarcillin
33%